niacinamide and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate

niacinamide has been researched along with 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aluisio, L; Ao, H; Bhattacharya, A; Bonaventure, P; Fraser, I; Letavic, MA; Lord, B; Lovenberg, TW; Neff, RA; Nepomuceno, D; Shoblock, JR; Wang, Q; Welty, N; Wickenden, AD	1
Alves, M; Arribas-Blázquez, M; Artalejo, AR; Bhattacharya, A; Conroy, RM; Delanty, N; Diaz-Hernandez, M; Engel, T; Farrell, MA; Henshall, DC; Jimenez-Pacheco, A; Letavic, M; Miras-Portugal, MT; O'Brien, DF; Olivos-Oré, LA; Sanz-Rodriguez, A	1

Other Studies

2 other study(ies) available for niacinamide and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate

Article	Year
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. British journal of pharmacology, 2013, Volume: 170, Issue:3 Topics: Adenosine Triphosphate; Analgesics; Animals; Antidepressive Agents; Antimanic Agents; Behavior, Animal; Binding, Competitive; Bipolar Disorder; Blood-Brain Barrier; Brain; Calcium Signaling; Capillary Permeability; Cell Line; Depression; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Humans; Interleukin-1beta; Macaca; Male; Mice; Mice, Inbred C57BL; Neuralgia; Niacinamide; Piperazines; Protein Binding; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Time Factors; Transfection	2013
Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 06-01, Volume: 36, Issue:22 Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Brain; Calcium-Binding Proteins; Disease Models, Animal; Epilepsy, Temporal Lobe; Gene Expression Regulation; Gliosis; Green Fluorescent Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Middle Aged; Nerve Tissue Proteins; Niacinamide; Piperazines; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Seizures; Up-Regulation; Young Adult	2016

Article

Year

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.

British journal of pharmacology, 2013, Volume: 170, Issue:3

Topics: Adenosine Triphosphate; Analgesics; Animals; Antidepressive Agents; Antimanic Agents; Behavior, Animal; Binding, Competitive; Bipolar Disorder; Blood-Brain Barrier; Brain; Calcium Signaling; Capillary Permeability; Cell Line; Depression; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Humans; Interleukin-1beta; Macaca; Male; Mice; Mice, Inbred C57BL; Neuralgia; Niacinamide; Piperazines; Protein Binding; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Time Factors; Transfection

2013

Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 06-01, Volume: 36, Issue:22

Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Brain; Calcium-Binding Proteins; Disease Models, Animal; Epilepsy, Temporal Lobe; Gene Expression Regulation; Gliosis; Green Fluorescent Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Middle Aged; Nerve Tissue Proteins; Niacinamide; Piperazines; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Seizures; Up-Regulation; Young Adult

2016